RNU6-759P

Across TCGA pan-cancer cohorts, RNU6-759P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RNU6-759P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-759P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-759P expression acts as an unfavorable survival marker, although some lineages such as LUAD and PAAD show a favorable association.

LUAD, ACC, and KICH are the cancer types where RNU6-759P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.348	0.190	<.001	90	view →
ACC	DFS	Median	All	0.318	0.753	<.001	89	view →
KICH	DFS	Quartile	III,IV	0.159	0.855	<.001	80	view →
LIHC	OS	Quartile	II,III,IV	0.256	0.500	<.001	59	view →
CESC	DFS	Tertile	III,IV	0.592	0.918	.005	58	view →
PAAD	DFS	Tertile	All	0.676	0.377	.001	40	view →
CHOL	DFS	Median	II,III,IV	0.690	0.151	.004	37	view →
OV	OS	Quartile	IV	0.406	0.868	<.001	30	view →
KIRC	DFS	Quartile	All	0.450	0.673	.004	20	view →
BLCA	OS	Quartile	II,III,IV	0.552	0.325	.014	15	view →
THYM	OS	Median	II,III,IV	0.962	0.696	.006	14	view →
THCA	DFS	Tertile	IV	0.409	0.785	.003	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RNU6-759P–LUAD (OS)

Open the LUAD breakdown →